At Emory Winship Cancer Institute, our goal for patients with multiple myeloma or other plasma cell disorders is to provide comprehensive, individualized, patient-centered care. We focus on all aspects of care for our patients including the initial treatment, transplantation, maintenance therapy and relapse.

We conduct both basic and clinical research. The mission for our basic/translational research program is to develop rationally designed combination therapies with novel therapeutics. Our clinical research program is very active and we have access to state of the art therapies through our participation in the Multiple Myeloma Research Consortium (MMRC).